+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dravet Syndrome Treatment Market 2024-2028

  • PDF Icon

    Report

  • 178 Pages
  • June 2024
  • Region: Global
  • TechNavio
  • ID: 5509306
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The dravet syndrome treatment market is forecasted to grow by USD 727.9 million during 2023-2028, accelerating at a CAGR of 10.87% during the forecast period. The report on the dravet syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth in special regulatory designations, increasing new product launches, and advancements in genetic therapeutics for DS treatment.

The dravet syndrome treatment market is segmented as below:

By Product

  • SGDs
  • TGDs
  • FGDs

By Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • E-commerce
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increased use of new-generation drugs as one of the prime reasons driving the dravet syndrome treatment market growth during the next few years. Also, advances in biomedical sciences and strong pipeline will lead to sizable demand in the market.

The report on the dravet syndrome treatment market covers the following areas:

  • Dravet syndrome treatment market sizing
  • Dravet syndrome treatment market forecast
  • Dravet syndrome treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dravet syndrome treatment market vendors that include AbbVie Inc., BIOCODEX SAS, Encoded Therapeutics Inc., Epygenix Therapeutics Inc., H Lundbeck AS, Jazz Pharmaceuticals PLC, Johnson and Johnson Services Inc., Lupin Ltd., PTC Therapeutics Inc., Stoke Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Supernus Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., UCB SA, Viatris Inc., Xenon Pharmaceuticals Inc., and Zydus Lifesciences Ltd. Also, the dravet syndrome treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Dravet Syndrome Treatment Market 2018 - 2022
Historic Market Size - Data Table on Global Dravet Syndrome Treatment Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 SGDs - Market size and forecast 2023-2028
Chart on SGDs - Market size and forecast 2023-2028 ($ million)
Data Table on SGDs - Market size and forecast 2023-2028 ($ million)
Chart on SGDs - Year-over-year growth 2023-2028 (%)
Data Table on SGDs - Year-over-year growth 2023-2028 (%)
6.4 TGDs - Market size and forecast 2023-2028
Chart on TGDs - Market size and forecast 2023-2028 ($ million)
Data Table on TGDs - Market size and forecast 2023-2028 ($ million)
Chart on TGDs - Year-over-year growth 2023-2028 (%)
Data Table on TGDs - Year-over-year growth 2023-2028 (%)
6.5 FGDs - Market size and forecast 2023-2028
Chart on FGDs - Market size and forecast 2023-2028 ($ million)
Data Table on FGDs - Market size and forecast 2023-2028 ($ million)
Chart on FGDs - Year-over-year growth 2023-2028 (%)
Data Table on FGDs - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2023-2028
Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacy - Market size and forecast 2023-2028
Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
7.5 E-commerce - Market size and forecast 2023-2028
Chart on E-commerce - Market size and forecast 2023-2028 ($ million)
Data Table on E-commerce - Market size and forecast 2023-2028 ($ million)
Chart on E-commerce - Year-over-year growth 2023-2028 (%)
Data Table on E-commerce - Year-over-year growth 2023-2028 (%)
7.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 BIOCODEX SAS
BIOCODEX SAS - Overview
BIOCODEX SAS - Product / Service
BIOCODEX SAS - Key offerings
12.5 Encoded Therapeutics Inc.
Encoded Therapeutics Inc. - Overview
Encoded Therapeutics Inc. - Product / Service
Encoded Therapeutics Inc. - Key offerings
12.6 Epygenix Therapeutics Inc.
Epygenix Therapeutics Inc. - Overview
Epygenix Therapeutics Inc. - Product / Service
Epygenix Therapeutics Inc. - Key offerings
12.7 H Lundbeck AS
H Lundbeck AS - Overview
H Lundbeck AS - Product / Service
H Lundbeck AS - Key offerings
12.8 Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc - Overview
Jazz Pharmaceuticals Plc - Product / Service
Jazz Pharmaceuticals Plc - Key news
Jazz Pharmaceuticals Plc - Key offerings
12.9 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.10 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Product / Service
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
12.11 PTC Therapeutics Inc.
PTC Therapeutics Inc. - Overview
PTC Therapeutics Inc. - Product / Service
PTC Therapeutics Inc. - Key offerings
12.12 Stoke Therapeutics Inc.
Stoke Therapeutics Inc. - Overview
Stoke Therapeutics Inc. - Product / Service
Stoke Therapeutics Inc. - Key offerings
12.13 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
12.14 Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc. - Overview
Supernus Pharmaceuticals Inc. - Product / Service
Supernus Pharmaceuticals Inc. - Key offerings
12.15 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
12.16 UCB SA
UCB SA - Overview
UCB SA - Product / Service
UCB SA - Key offerings
12.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Dravet Syndrome Treatment Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Product - Market share 2023-2028 (%)
Exhibits 33: Data Table on Product - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Product
Exhibits 35: Data Table on Comparison by Product
Exhibits 36: Chart on SGDs - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on SGDs - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on SGDs - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on SGDs - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on TGDs - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on TGDs - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on TGDs - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on TGDs - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on FGDs - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on FGDs - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on FGDs - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on FGDs - Year-over-year growth 2023-2028 (%)
Exhibits 48: Market opportunity by Product ($ million)
Exhibits 49: Data Table on Market opportunity by Product ($ million)
Exhibits 50: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 51: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 52: Chart on Comparison by Distribution Channel
Exhibits 53: Data Table on Comparison by Distribution Channel
Exhibits 54: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 58: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on E-commerce - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on E-commerce - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on E-commerce - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on E-commerce - Year-over-year growth 2023-2028 (%)
Exhibits 66: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 69: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 70: Market opportunity by Distribution Channel ($ million)
Exhibits 71: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 73: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 74: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 75: Chart on Geographic comparison
Exhibits 76: Data Table on Geographic comparison
Exhibits 77: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 110: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 111: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 113: Market opportunity By Geographical Landscape ($ million)
Exhibits 114: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 115: Impact of drivers and challenges in 2023 and 2028
Exhibits 116: Overview on criticality of inputs and factors of differentiation
Exhibits 117: Overview on factors of disruption
Exhibits 118: Impact of key risks on business
Exhibits 119: Companies covered
Exhibits 120: Matrix on companies position and classification
Exhibits 121: AbbVie Inc. - Overview
Exhibits 122: AbbVie Inc. - Product / Service
Exhibits 123: AbbVie Inc. - Key news
Exhibits 124: AbbVie Inc. - Key offerings
Exhibits 125: BIOCODEX SAS - Overview
Exhibits 126: BIOCODEX SAS - Product / Service
Exhibits 127: BIOCODEX SAS - Key offerings
Exhibits 128: Encoded Therapeutics Inc. - Overview
Exhibits 129: Encoded Therapeutics Inc. - Product / Service
Exhibits 130: Encoded Therapeutics Inc. - Key offerings
Exhibits 131: Epygenix Therapeutics Inc. - Overview
Exhibits 132: Epygenix Therapeutics Inc. - Product / Service
Exhibits 133: Epygenix Therapeutics Inc. - Key offerings
Exhibits 134: H Lundbeck AS - Overview
Exhibits 135: H Lundbeck AS - Product / Service
Exhibits 136: H Lundbeck AS - Key offerings
Exhibits 137: Jazz Pharmaceuticals Plc - Overview
Exhibits 138: Jazz Pharmaceuticals Plc - Product / Service
Exhibits 139: Jazz Pharmaceuticals Plc - Key news
Exhibits 140: Jazz Pharmaceuticals Plc - Key offerings
Exhibits 141: Johnson and Johnson Services Inc. - Overview
Exhibits 142: Johnson and Johnson Services Inc. - Business segments
Exhibits 143: Johnson and Johnson Services Inc. - Key news
Exhibits 144: Johnson and Johnson Services Inc. - Key offerings
Exhibits 145: Johnson and Johnson Services Inc. - Segment focus
Exhibits 146: Lupin Ltd. - Overview
Exhibits 147: Lupin Ltd. - Product / Service
Exhibits 148: Lupin Ltd. - Key news
Exhibits 149: Lupin Ltd. - Key offerings
Exhibits 150: PTC Therapeutics Inc. - Overview
Exhibits 151: PTC Therapeutics Inc. - Product / Service
Exhibits 152: PTC Therapeutics Inc. - Key offerings
Exhibits 153: Stoke Therapeutics Inc. - Overview
Exhibits 154: Stoke Therapeutics Inc. - Product / Service
Exhibits 155: Stoke Therapeutics Inc. - Key offerings
Exhibits 156: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 157: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 158: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 159: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 160: Supernus Pharmaceuticals Inc. - Overview
Exhibits 161: Supernus Pharmaceuticals Inc. - Product / Service
Exhibits 162: Supernus Pharmaceuticals Inc. - Key offerings
Exhibits 163: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 164: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 165: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 166: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 167: UCB SA - Overview
Exhibits 168: UCB SA - Product / Service
Exhibits 169: UCB SA - Key offerings
Exhibits 170: Viatris Inc. - Overview
Exhibits 171: Viatris Inc. - Business segments
Exhibits 172: Viatris Inc. - Key news
Exhibits 173: Viatris Inc. - Key offerings
Exhibits 174: Viatris Inc. - Segment focus
Exhibits 175: Inclusions checklist
Exhibits 176: Exclusions checklist
Exhibits 177: Currency conversion rates for US$
Exhibits 178: Research methodology
Exhibits 179: Information sources
Exhibits 180: Data validation
Exhibits 181: Validation techniques employed for market sizing
Exhibits 182: Data synthesis
Exhibits 183: 360 degree market analysis
Exhibits 184: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global dravet syndrome treatment market: AbbVie Inc., BIOCODEX SAS, Encoded Therapeutics Inc., Epygenix Therapeutics Inc., H Lundbeck AS, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Lupin Ltd., PTC Therapeutics Inc., Stoke Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Supernus Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., UCB SA, Viatris Inc., Xenon Pharmaceuticals Inc., and Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increased use of new-generation drugs."

According to the report, one of the major drivers for this market is the growth in special regulatory designations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • BIOCODEX SAS
  • Encoded Therapeutics Inc.
  • Epygenix Therapeutics Inc.
  • H Lundbeck AS
  • Jazz Pharmaceuticals Plc
  • Johnson and Johnson Services Inc.
  • Lupin Ltd.
  • PTC Therapeutics Inc.
  • Stoke Therapeutics Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Supernus Pharmaceuticals Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Thermo Fisher Scientific Inc.
  • UCB SA
  • Viatris Inc.
  • Xenon Pharmaceuticals Inc.
  • Zydus Lifesciences Ltd.